Kala Pharmaceuticals Inc.
13F holders, Q3 2025 (September 30)2holders
0new positions
0sold out
$0.84avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Kala Pharmaceuticals Inc. in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Cheviot Value Management, LLC ($127) and Parallel Advisors, LLC ($2).
- Company
- Kala Pharmaceuticals Inc.
- Filed as
- KALA BIO INC COM NEW (Q3 2025)
- CUSIP
- 483119103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Cheviot Value Management, LLC | 0.00% | No change | 153 | $127 |
| Parallel Advisors, LLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is KALA PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Kala Pharmaceuticals Inc. the manager owns.